~~<i id='D7746C69E6'><strike id='D7746C69E6'><tt id='D7746C69E6'><pre id='D7746C69E6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：entertainment 2025-10-03 00:39:16 - browse：392

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Be careful with at

knowledge

explore

focus

hotspot

ChrisViehbachertookoverasBiogenCEOinNovember.SuzanneKreiter/Globestaff;PhotoillustrationAlexHogan/ST

WSS

Dozens dead from Maui wildfires: What we know about the victims

N.Y. state detects polio case, first in the U.S. since 2013

It's time to get medical device identifiers over the finish line

What to know about the judge who will handle the Trump case

NIH fellows want a pay raise. Will that mean less money for grants?

Surge in Apellis stock fueled by confidence in safety of its eye drug

entertainment

leisure time

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Study: Pain burden is higher in Black NFL players than white ones

Alkermes shareholders re

Biden administration begins canceling student loan debt for 804,000 borrowers

Hepatitis C has a cure — but many Americans still lack access to it

Why ADHD is under

State Dept. review finds Biden bears some blame for Afghanistan failures

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Anesthesiologist group: stop taking Ozempic before surgery

Idaho college killings prosecutors challenge defense's grand jury claims

explore

What to know about the judge who will handle the Trump case

Hospitals are dialing back on venture capital investing

Oak trusses raised to roof of fire

Be careful with at

Illumina slashes 2023 revenue projections yet again

Beach reads and more: STAT's 2023 summer book list

focus

focus

focus

hotspot